Delivery Order SPE2DB20D2014-SPE2DB26FA15J
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,687.48 to AmerisourceBergen Drug Corp for PROQUAD vials, with a completion date of September 26, 2025. This is a firm fixed-price contract awarded competitively without a set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger vehicle, this delivery order leverages AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency's Medical Supply Chain awarded a $16.5K firm fixed-price delivery order to AmerisourceBergen Drug Corp for PROQUAD vials, with an ultimate completion date of October 14, 2025. This competitive award, issued on September 22, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order operates under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion...
- The Defense Logistics Agency awarded a $1,687.48 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for ProQuad vials with a completion date of August 29, 2025. This firm fixed-price, non-set-aside contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child order under a larger contract vehicle, this delivery order leverages AmerisourceBergen's established relationships with DLA for pharmaceutical supply to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,687.48 to AmerisourceBergen Drug Corp for PROQUAD vials, with a firm fixed price structure and ultimate completion date of September 3, 2025. This is a non-set-aside, competitively awarded contract representing a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award is classified as a child contract, indicating it derives from a larger prime...
- The Defense Logistics Agency awarded a delivery order valued at $3,374.96 to AmerisourceBergen Drug Corp on May 12, 2025, for PROQUAD vials, with a completion date of June 3, 2025. This non-set-aside, firm fixed-price delivery order will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems, with...
- The Defense Logistics Agency awarded a delivery order valued at $5,480.80 to AmerisourceBergen Drug Corp for PROQUAD vials, a vaccine product, with a completion date of September 19, 2025. This competitively awarded, firm fixed-price delivery order was placed with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as...
- The Defense Logistics Agency awarded a delivery order valued at $3,341.80 to AmerisourceBergen Drug Corp for PROQUAD vials, with an ultimate completion date of September 17, 2025. This is a firm fixed price, non-set-aside delivery order issued under a competitive procurement process. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,543.30 to AmerisourceBergen Drug Corp for ProQuad vials on September 12, 2025, with an ultimate completion date of October 3, 2025. This firm fixed-price delivery order, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $9,925.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PROQUAD vials with an ultimate completion date of October 16, 2025. This non-set-aside contract, awarded on September 24, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026. The delivery order will be fulfilled at...
- The Defense Logistics Agency awarded a delivery order valued at $3,374.88 to AmerisourceBergen Drug Corp for ProQuad vials on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The delivery order will be fulfilled at AmerisourceBergen's corporate office...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB26FA15JDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,687.44 to AmerisourceBergen Drug Corp for PROQUAD vials on October 22, 2025, with completion targeted for November 13, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.999 billion through December 2026. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its comprehensive supply agreements with DLA. The company's federal portfolio encompasses a wide range of pharmaceutical products and medical supplies including vaccines, medications, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems globally. This specific delivery order for PROQUAD vials—a combination vaccine product—reflects the contractor's ongoing role in fulfilling immunization and preventive medicine requirements across the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 10/22/25 |